Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Karen, Seibert"'
Autor:
Amy Bellinghausen Stewart, Dana Villines, Tahira Yasmeen, Joel Saeedi, Michael D. Ries, Joumana Chaiban, Karen Seibert
Publikováno v:
Critical Care Medicine. 48:139-139
Autor:
Karen Seibert, Christina M. Lockwood, Daniel Morgensztern, Kalin Guebert, Rakesh Nagarajan, Hussam Al-Kateb, Saiama N. Waqar, Catherine E. Cottrell, David H. Spencer, TuDung T. Nguyen, Maria Q. Baggstrom, John D. Pfeifer, Siddhartha Devarakonda, Ian S. Hagemann, Andrew J. Bredemeyer, Shashikant Kulkarni, Eric J. Duncavage, Ramaswamy Govindan
Publikováno v:
Cancer. 121:631-639
BACKGROUND A clinical assay was implemented to perform next-generation sequencing (NGS) of genes commonly mutated in multiple cancer types. This report describes the feasibility and diagnostic yield of this assay in 381 consecutive patients with non
Autor:
Justin T. Brown, Mark R. Johnson, Leslie D. McIntosh, Christina M. Lockwood, David H. Spencer, Stephanie M. O’Guin, Mark A. Watson, Catherine E. Cottrell, John D. Pfeifer, Christopher S. Sawyer, Jacqueline E. Payton, Jennifer L. Stratman, Jeffrey Milbrandt, Eric J. Duncavage, Herbert W. Virgin, Rakesh Nagarajan, Andrew J. Bredemeyer, Paul F. Cliften, Ian S. Hagemann, Bijoy George, Karen Seibert, Shashikant Kulkarni, TuDung T. Nguyen, Hussam Al-Kateb, Dayna M. Oschwald, Robi D. Mitra, Savita Shrivastava, Dorie A. Sher, Lauren C. Burcea, Seth D. Crosby, Richard D. Head, Haley J. Abel
Publikováno v:
The Journal of Molecular Diagnostics. 16:89-105
Currently, oncology testing includes molecular studies and cytogenetic analysis to detect genetic aberrations of clinical significance. Next-generation sequencing (NGS) allows rapid analysis of multiple genes for clinically actionable somatic variant
Autor:
Louis C. Gerstenfeld, Deborah Phippard, Cindy Mielke, Thomas A. Einhorn, Karen Seibert, Dennis M. Cullinane, Mark Thiede, Bohus Svagr
Publikováno v:
Journal of Orthopaedic Research. 21:670-675
Non-steroidal anti-inflammatory drugs (NSAIDs) specifically inhibit cyclooxygenase (COX) activity and are widely used as anti-arthritics, post-surgical analgesics, and for the relief of acute musculoskeletal pain. Recent studies suggest that non-spec
Autor:
Paola Ciceri, Walter G. Smith, Kathleen M. Leahy, Karen Seibert, Peter C. Isakson, Yan Zhang, Alex Shaffer, Mark B. Woerner
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 302:846-852
Prostaglandin E(2) (PGE(2)) is the major prostaglandin produced both centrally and in the periphery in models of acute and chronic inflammation, and its formation in both locations is blocked by cyclooxygenase-2 (COX-2) inhibitors such as celecoxib.
Autor:
Ian S, Hagemann, Siddhartha, Devarakonda, Christina M, Lockwood, David H, Spencer, Kalin, Guebert, Andrew J, Bredemeyer, Hussam, Al-Kateb, TuDung T, Nguyen, Eric J, Duncavage, Catherine E, Cottrell, Shashikant, Kulkarni, Rakesh, Nagarajan, Karen, Seibert, Maria, Baggstrom, Saiama N, Waqar, John D, Pfeifer, Daniel, Morgensztern, Ramaswamy, Govindan
Publikováno v:
Cancer. 121(4)
A clinical assay was implemented to perform next-generation sequencing (NGS) of genes commonly mutated in multiple cancer types. This report describes the feasibility and diagnostic yield of this assay in 381 consecutive patients with non-small cell
Autor:
Mark C. WALKER, Ravi G. KURUMBAIL, James R. KIEFER, Kirby T. MORELAND, Carol M. KOBOLDT, Peter C. ISAKSON, Karen SEIBERT, James K. GIERSE
Publikováno v:
Biochemical Journal. 357:709-718
Cyclo-oxygenase (COX) enzymes are the targets for non-steroidal anti-inflammatory drugs (NSAIDs). These drugs demonstrate a variety of inhibitory mechanisms, which include simple competitive, as well as slow binding and irreversible inhibition. In ge
Autor:
Mukesh K, Sharma, Joshua, Phillips, Saurabh, Agarwal, Wesley S, Wiggins, Savita, Shrivastava, Sunita B, Koul, Madhurima, Bhattacharjee, Caerie D, Houchins, Raghavendra R, Kalakota, Bijoy, George, Rekha R, Meyer, David H, Spencer, Christina M, Lockwood, Tudung T, Nguyen, Eric J, Duncavage, Hussam, Al-Kateb, Catherine E, Cottrell, Suhasini, Godala, Raviteja, Lokineni, Sameer M, Sawant, Vasudev, Chatti, Suresh, Surampudi, Raja Rao, Sunkishala, Ramakant, Darbha, Sharath, Macharla, Jeffrey D, Milbrandt, Herbert W, Virgin, Robi D, Mitra, Richard D, Head, Shashikant, Kulkarni, Andrew, Bredemeyer, John D, Pfeifer, Karen, Seibert, Rakesh, Nagarajan
Publikováno v:
AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science. 2013
The use of NextGen Sequencing clinically necessitates the need for informatics tools that support the complete workflow from sample accessioning to data analysis and reporting. To address this need we have developed Clinical Genomicist Workstation (C
Autor:
Karen Seibert, Gary J. Kelloff, Claudio J. Conti, Herng-Hsang Lo, Gary Gordon, Ronald A. Lubet, Susan M. Fischer
Publikováno v:
Molecular Carcinogenesis. 25:231-240
Epidemiological and dietary studies suggest that nonsteroidal anti-inflammatory drugs (NSAIDs) reduce the risk of colon cancer, possibly through a mechanism involving inhibition of cyclooxygenase (COX)-2, which is overexpressed in premalignant adenom
Autor:
Jeffery S. Carter, John J. Talley, Karen Seibert, Stephen R. Bertenshaw, D. Joseph Rogier, Carol M. Koboldt, Graneto Matthew J, David L. Brown, Ben S. Zweifel, Jaime L. Masferrer, Bryan H. Norman
Publikováno v:
Medicinal Research Reviews. 19:199-208
A series of methysulfonyl or sulfonamido substituted 4,5-diaryloxazole were prepared and evaluated for their ability to inhibit the inducible form of cyclooxygenase (COX-2) in vitro and in vivo. Several unique substitution patterns were identified th